I asked about a timeline for safety results, heres the answer:
Dear Sean,
Thanks for your email through the Benitec website. It's possible we may have some interim safety data available by the end of the year.
We'll continue to keep the market updated as we make progress on the trial.
Best regards,
Jane Jane Lowe | Investor Relations Benitec Biopharma Limited | F6A / 1-15 Barr Street | Balmain NSW 2041 Australia ABN: 64068943662 t: (+61 2) 9555 6986 | m: (+61) 411 117 774| e:
[email protected] | w:
www.benitec.com